Showing results (1-10 of 566) with videos related to

Sort By:
Pageof 57
Rheumatology and Therapy|August 9, 2024
Summary of Research: Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RAVibeke Strand
Autoimmunity Reviews|February 24, 2007
Lessons learned from clinical trials in SLEVibeke Strand
Journal of Cardiovascular Pharmacology|June 21, 2006
Expectations from patients with rheumatoid arthritis regarding COX-2s: cutting to the heart of the matterVibeke Strand
Lancet (London, England)|December 25, 2007
Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?Vibeke Strand
Expert Review of Clinical Immunology|March 3, 2022
Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritisVibeke Strand
Rheumatology and Therapy|June 11, 2025
Summary of Research: Immunogenicity of Adalimumab Reference Product and Adalimumab-adbm in Patients with Rheumatoid Arthritis, Crohn's Disease, and Chronic Plaque Psoriasis: A Pooled Analysis of the VOLTAIRE trialsVibeke Strand
Clinical Rheumatology|January 7, 2021
Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical updateYashaar Chaichian, Vibeke Strand
Bulletin of the NYU Hospital for Joint Diseases|October 26, 2010
Rheumatoid arthritis classification criteria - It's finally time to move on!Jeremy Sokolove, Vibeke Strand
Annals of the Academy of Medicine, Singapore|March 17, 2007
Health-related quality of life in patients with systemic lupus erythematosus: an updateJulian Thumboo, Vibeke Strand
Bulletin of the NYU Hospital for Joint Diseases|October 10, 2007
Interleukin-6 inhibition--tolerability profile and clinical implicationsVibeke Strand, Yusuf Yazici
Pageof 57